(a) A medical facility or research facility shall not use genetic sequencers, or any operational or research software used for genetic sequencing, produced in or by a foreign adversary, a state-owned enterprise of a foreign adversary, a company domiciled within a foreign adversary, or a subsidiary or affiliate that is owned or controlled by a company domiciled within a foreign adversary.
(b) All genetic sequencers and operational and research software used for genetic sequencers or genetic sequencing devices prohibited under subsection (a), which are not permanently disabled, must be removed and replaced within one hundred eighty (180) days after January 1, 2026, with genetic sequencers and operational and research software used for genetic sequencers or genetic sequencing in compliance with this section.
(c) A medical facility or research facility is not required to investigate any individual component of genetic sequencing equipment or software to be in compliance with this section.